According to the latest results of a large screening trial, annual screening for prostate cancer doesn’t cut men’s chances of dying from the disease.
Researchers found while comparing men who were screened each year with so-called PSA tests, for prostate specific antigen, or rectal exams to those who received their usual care that more men in the screening group had been diagnosed with prostate cancer after 13 years and there was no difference in how many had died from it.
“Men, if they’re considering screening, should be aware that there’s a possibility that there’s little or no benefit (and) that there certainly are harms to PSA screening,” said study co-author Philip Prorok, from the National Cancer Institute in Bethesda, Maryland.
Related Posts
Tags: prostate cancer, PSA screening
